These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28981753)

  • 1. Designing Fcabs: well-expressed and stable high affinity antigen-binding Fc fragments.
    Wozniak-Knopp G; Stadlmayr G; Perthold JW; Stadlbauer K; Woisetschläger M; Sun H; Rüker F
    Protein Eng Des Sel; 2017 Sep; 30(9):657-671. PubMed ID: 28981753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creating stable stem regions for loop elongation in Fcabs - insights from combining yeast surface display, in silico loop reconstruction and molecular dynamics simulations.
    Hasenhindl C; Lai B; Delgado J; Traxlmayr MW; Stadlmayr G; Rüker F; Serrano L; Oostenbrink C; Obinger C
    Biochim Biophys Acta; 2014 Sep; 1844(9):1530-40. PubMed ID: 24792385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.
    Lobner E; Humm AS; Mlynek G; Kubinger K; Kitzmüller M; Traxlmayr MW; Djinović-Carugo K; Obinger C
    MAbs; 2017 Oct; 9(7):1088-1104. PubMed ID: 28816592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directed evolution of Her2/neu-binding IgG1-Fc for improved stability and resistance to aggregation by using yeast surface display.
    Traxlmayr MW; Lobner E; Antes B; Kainer M; Wiederkum S; Hasenhindl C; Stadlmayr G; Rüker F; Woisetschläger M; Moulder K; Obinger C
    Protein Eng Des Sel; 2013 Apr; 26(4):255-65. PubMed ID: 23267121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.
    Wozniak-Knopp G; Bartl S; Bauer A; Mostageer M; Woisetschläger M; Antes B; Ettl K; Kainer M; Weberhofer G; Wiederkum S; Himmler G; Mudde GC; Rüker F
    Protein Eng Des Sel; 2010 Apr; 23(4):289-97. PubMed ID: 20150180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast Surface Display and Cell Sorting of Antigen-Binding Fc Fragments.
    Sádio F; Stadlmayr G; Stadlbauer K; Rüker F; Wozniak-Knopp G
    Methods Mol Biol; 2019; 1923():287-308. PubMed ID: 30737746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered IgG1-Fc--one fragment to bind them all.
    Lobner E; Traxlmayr MW; Obinger C; Hasenhindl C
    Immunol Rev; 2016 Mar; 270(1):113-31. PubMed ID: 26864108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening.
    Choi HJ; Kim YJ; Choi DK; Kim YS
    PLoS One; 2015; 10(12):e0145349. PubMed ID: 26675656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fcab-HER2 Interaction: a Ménage à Trois. Lessons from X-Ray and Solution Studies.
    Lobner E; Humm AS; Göritzer K; Mlynek G; Puchinger MG; Hasenhindl C; Rüker F; Traxlmayr MW; Djinović-Carugo K; Obinger C
    Structure; 2017 Jun; 25(6):878-889.e5. PubMed ID: 28528777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between CD16a binding and immuno effector functionality of an antigen specific immunoglobulin Fc fragment (Fcab).
    Kainer M; Antes B; Wiederkum S; Wozniak-Knopp G; Bauer A; Rüker F; Woisetschläger M
    Arch Biochem Biophys; 2012 Oct; 526(2):154-8. PubMed ID: 22634259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro activity of an immunoglobulin Fc fragment (Fcab) with engineered Her-2/neu binding sites.
    Woisetschläger M; Antes B; Borrowdale R; Wiederkum S; Kainer M; Steinkellner H; Wozniak-Knopp G; Moulder K; Rüker F; Mudde GC
    Biotechnol J; 2014 Jun; 9(6):844-51. PubMed ID: 24806546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.
    Traxlmayr MW; Lobner E; Hasenhindl C; Stadlmayr G; Oostenbrink C; Rüker F; Obinger C
    Biotechnol J; 2014 Aug; 9(8):1013-22. PubMed ID: 24964247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of High-Affinity Heterodimeric Antigen-Binding Fc Fragments from a Large Yeast Display Library.
    Benedetti F; Stadlmayr G; Stadlbauer K; Rüker F; Wozniak-Knopp G
    Methods Mol Biol; 2023; 2681():131-159. PubMed ID: 37405647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.
    Bailey LJ; Sheehy KM; Hoey RJ; Schaefer ZP; Ura M; Kossiakoff AA
    J Immunol Methods; 2014 Dec; 415():24-30. PubMed ID: 25450256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding.
    Zwolak A; Leettola CN; Tam SH; Goulet DR; Derebe MG; Pardinas JR; Zheng S; Decker R; Emmell E; Chiu ML
    Sci Rep; 2017 Nov; 7(1):15521. PubMed ID: 29138497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
    Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
    Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity.
    Liu L; Yu H; Huang X; Tan H; Li S; Luo Y; Zhang L; Jiang S; Jia H; Xiong Y; Zhang R; Huang Y; Chu CC; Tian W
    BMC Cancer; 2015 Mar; 15():170. PubMed ID: 25881012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.
    Wozniak-Knopp G; Stadlmann J; Rüker F
    PLoS One; 2012; 7(1):e30083. PubMed ID: 22272277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.